Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Passamani

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1985
Survival following coronary artery bypass grafting in patients with severe angina pectoris (CASS). An observational studyG C Kaiser, K B Davis, L D Fisher, et al.
Circulation|November 1, 1986
The role of coronary bypass surgery for 'left main equivalent' coronary disease: the Coronary Artery Surgery Study registryB R Chaitman, K B Davis, G C Kaiser, et al.
Circulation|April 1, 1987
The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trialF H Sheehan, E Braunwald, P Canner, et al.
Journal of the American College of Cardiology|April 1, 1990
The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectivesD S Baim, E Braunwald, F Feit, et al.
British Heart Journal|October 1, 1988
Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS)R Roberts, E Braunwald, J E Muller, et al.
The New England Journal of Medicine|July 26, 1984
Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trialR Roberts, C Croft, H K Gold, et al.
The New England Journal of Medicine|August 21, 1975
Limitations of the electrocardiographic response to exercise in predicting coronary-artery diseaseJ S Borer, J F Brensike, D R Redwood, et al.
Journal of the American College of Cardiology|April 1, 1991
Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II InvestigatorsW J Rogers, J D Babb, D S Baim, et al.
The American Journal of Cardiology|March 1, 1989
Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot studyW J Rogers, R C Bourge, S E Papapietro, et al.
Journal of the American College of Cardiology|November 1, 1987
Prognostic implications of an early peak in plasma MB creatine kinase in patients with acute myocardial infarctionD A Cox, P H Stone, J E Muller, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1985
Survival following coronary artery bypass grafting in patients with severe angina pectoris (CASS). An observational studyG C Kaiser, K B Davis, L D Fisher, et al.
Circulation|November 1, 1986
The role of coronary bypass surgery for 'left main equivalent' coronary disease: the Coronary Artery Surgery Study registryB R Chaitman, K B Davis, G C Kaiser, et al.
Circulation|April 1, 1987
The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trialF H Sheehan, E Braunwald, P Canner, et al.
Journal of the American College of Cardiology|April 1, 1990
The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectivesD S Baim, E Braunwald, F Feit, et al.
British Heart Journal|October 1, 1988
Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS)R Roberts, E Braunwald, J E Muller, et al.
The New England Journal of Medicine|July 26, 1984
Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trialR Roberts, C Croft, H K Gold, et al.
The New England Journal of Medicine|August 21, 1975
Limitations of the electrocardiographic response to exercise in predicting coronary-artery diseaseJ S Borer, J F Brensike, D R Redwood, et al.
Journal of the American College of Cardiology|April 1, 1991
Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II InvestigatorsW J Rogers, J D Babb, D S Baim, et al.
The American Journal of Cardiology|March 1, 1989
Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot studyW J Rogers, R C Bourge, S E Papapietro, et al.
Journal of the American College of Cardiology|November 1, 1987
Prognostic implications of an early peak in plasma MB creatine kinase in patients with acute myocardial infarctionD A Cox, P H Stone, J E Muller, et al.
Pageof 3